Skip to content

Anagrelide capsules recalled due to test failure

These anagrelide capsules are being recalled.

Anagrelide Capsules recall. Photo sourced from FDA.

Teva issued a recall for Anagrelide Capsules due to dissolution test failure.


Salmonella: Cargill recalls 795 boxes of product

Anagrelide Capsules recall

According to an article by the FDA the company Teva is having a recall on Anagrelide Capsules.

These capsules failed the dissolution test which means they do not dissolve correctly.


If a pill does not dissolve correctly then it becomes less effective.

Only one lot of capsules are affected by this alert.

The product name and lot number are listed below

  • Anagrelide Capsules – GD01090

These were distributed nationwide.

Teva notified their customers on May 11, 2022, to inform them of this recall.

Anyone who has these capsules should return them to the company.


Top